Cycrin and Ultrasound breast abnormal - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Cycrin?
Cycrin has active ingredients of medroxyprogesterone acetate. Currently, eHealthMe is studying from 5,086 Cycrin users.
What is Ultrasound Breast Abnormal?
Ultrasound breast abnormal is found to be associated with 104 drugs and 80 conditions by eHealthMe. Currently, we are studying 45 people who have Ultrasound breast abnormal.
Do you take Cycrin and have Ultrasound breast abnormal?Check whether Ultrasound breast abnormal is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Cycrin side effects by duration, gender and age:
- Cycrin side effects (5,086 reports)
Ultrasound breast abnormal treatments and more:
- Ultrasound breast abnormal (45 reports)
All the drugs that are associated with Ultrasound breast abnormal:
All the conditions that are associated with Ultrasound breast abnormal:
How the study uses the data?
The study uses data from the FDA. It is based on medroxyprogesterone acetate (the active ingredients of Cycrin) and Cycrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Byetta and Weight Decreased - a second ago
- Profen and Complement Factor C4 Decreased - 6 seconds ago
- Voltaren and Sandostatin Lar drug interaction - 11 seconds ago
- Cytoxan and Joint Pain - 17 seconds ago
- Tobi Podhaler and Noxafil drug interaction - 20 seconds ago
- Atazanavir and Hyponatremia - 20 seconds ago
- Desonide and Librax drug interaction - 21 seconds ago
- Dilaudid and Basal Cell Carcinoma - 26 seconds ago
- Xyzal and Multiple Sclerosis - 28 seconds ago
- Estazolam and Joint Pain - 37 seconds ago